Monthly Archives: February 2022
News
U.S. FDA approves AbbVie’s VYALEV for adults living with advanced Parkinson’s disease
The U.S. Food and Drug Administration (FDA) has approved AbbVie's VYALEV (foscarbidopa and foslevodopa) as the first and only subcutaneous 24-hour infusion of levodopa-based...
U.S. FDA approves Pfizer’s HYMPAVZI for adults and adolescents with hemophilia A or B...
The U.S. Food and Drug Administration (FDA) has approved Pfizer's HYMPAVZI (marstacimab-hncq) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes...
Lundbeck to acquire Longboard Pharmaceuticals
Lundbeck is set to acquire Longboard Pharmaceuticals.
Under the terms of the agreement, Lundbeck will commence a tender offer for all outstanding shares of Longboard...
